Flow cytometry is of limited utility in the early identification of "double-hit" B-cell lymphomas

Cytometry Part B - Clinical Cytometry

Volumn 84 B, Issue 3, 2013, Pages 143-148

  Platt, Mia Y ^a   Delelys, Michelle E ^a   Preffer, Frederic I ^a   Sohani, Aliyah R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BCL2; BCL6; CD19; CD20; double hit lymphoma; flow cytometry; MYC

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOUBLE HIT B CELL LYMPHOMA; EARLY DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; ANTIGENS, CD19; ANTIGENS, CD20; BURKITT LYMPHOMA; CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; RETROSPECTIVE STUDIES;

EID: 84876482519     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21076     Document Type: Article

References (14)

1. Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM,. Double-hit B-cell lymphomas. Blood 2011; 117: 2319-2331.
2. Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E, Jaffe ES,. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In:, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: IARC Press; 2008. p 265-266.
3. Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010; 34: 327-340.
4. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009; 114: 2273-2279.
5. Niitsu N, Okamoto M, Miura I, Hirano M,. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia 2009; 23: 777-783.
6. Wu D, Wood BL, Dorer R, Fromm JR,. Double-Hit mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression. Am J Clin Pathol 2010; 134: 258-265.
7. Harrington AM, Olteanu H, Kroft SH, Eshoa C,. The unique immunophenotype of double-hit lymphomas. Am J Clin Pathol 2011; 135: 649-650.
8. Leoncini L, Raphael M, Stein H, Harris NL, Jaffe ES, Kluin PM,. Burkitt lymphoma. In:, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008. p 262-264.
9. Cannizzo E, Bellio E, Sohani AR, Hasserjian RP, Ferry JA, Dorn ME, Sadowski C, Bucci JJ, Carulli G, Preffer F,. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology. Cytometry B Clin Cytom 2010; 78B: 231-238.
10. Dzik WH, Cserti-Gazdewich CM, Ssewanyana I, Delelys M, Preffer FI,. When monocytes and platelets compete: The effect of platelet count on the flow cytometric measurement of monocyte CD36. Cytometry B Clin Cytom 2010; 78B: 81-87.
11. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282.
12. Green TM, Nielsen O, de Stricker K, Xu-Monette ZY, Young KH, Moller MB,. High Levels of Nuclear MYC Protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma. Am J Surg Pathol 2012; 36: 612-619.
13. Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, et al. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 2012; 30: 3452-3459.
14. Kluk MJ, Chapuy B, Sinha P, Roy A, Dal Cin P, Neuberg DS, Monti S, Pinkus GS, Shipp MA, Rodig SJ,. Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas. PLoS One 2012; 7: e33813.